Parkinson's Disease/Movement Disorders News

In dyads of Parkinson’s disease patients and caregivers, caregivers with a higher risk for depression were associated with patients’ lower quality of life and higher number of annual ED visits.

The FDA has approved once-daily Ingrezza capsules for adults with chorea associated with Huntington’s disease.

An oral, extended-release therapeutic provided more ‘good’ on-time in fewer daily doses compared with immediate-release carbidopa/levodopa in Parkinson’s disease with motor fluctuations, according to research presented in JAMA Neurology.

Older women with Parkinson’s disease were less physically active and spent more time being sedentary compared with those without Parkinson’s disease, which may increase their risk for adverse outcomes, according to researchers.

Among a cohort of adult males who played sports, participation in football was associated with higher odds of self-reported parkinsonism or Parkinson’s disease, with length of play and level of play associated with higher odds of both.

NYU Langone Hospitals was named the top hospital in the United States for neurology and neurosurgery by the U.S. News & World Report’s annual Best Hospitals survey.

Rates of adverse events were similar in both the pimavanserin group and placebo group.Pimavanserin was well-tolerated and not associated with cognitive decline or motor dysfunction in older adults with Parkinson’s disease and neuropsychiatric symptoms, according to a poster presentation.

BOSTON — With a multitude of products spanning neuroscience and psychiatry, executives at AbbVie say they are committed to learning the full clinical value of all of the company’s products for the benefit of patients.

The FDA has approved a software update for a deep brain stimulation system intended to assist clinicians in the treatment of those with Parkinson’s disease or essential tremor.

Patients with rheumatoid arthritis demonstrate a nearly 1.5-fold increased risk for developing Parkinson’s disease vs. those without RA, according to data published in JAMA Neurology.